LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($1.16). Revenue for the quarter came in at $1.59 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.